CA 15-3, a specific tumour marker for breast cancer?
نویسندگان
چکیده
منابع مشابه
Tumor marker CA 15-3 in breast cancer patients.
OBJECTIVE The aim of this study was to determine whether there is a correlation between the serum concentration of the tumor marker CA 15-3 and breast cancer, which has not been proven by the existence of regional and distant metastases, and breast cancer with the presence of regional and distant metastases. PATIENTS AND METHODS The study was a retrospective-prospective study, and was conduct...
متن کاملSensitivity and Specificity of CA 15-3 in Detection of Breast Cancer Recurrence
Background: The value of CA15-3(cancer antigen 15-3) marker in early detection of breast cancer recurrence has been studied in several prospective trials. But the results of these studies are different. This may be due to variable cutoff points used for analysis, different intervals between CA15-3 measurements and the differences between patients population. This study was done to examine the p...
متن کاملDiabetic type 2 and breast cancer marker CA 15 . 3 value
In this study we intended to assess the serum tumor marker CA 15.3 among diabetic females in comparison to non diabetic females without neoplasia and any other diabetic complication. Results indicate that there is statically significance between diabetic and non-diabetic females, although the levels are within the normal range of method used. It reveals that serum tumor marker CA 15.3 is useful...
متن کاملThe relation between tumor marker Ca 15-3 and metastases in interpectoral lymph nodes in breast cancer patients.
OBJECTIVE We aimed at analyzing the metastatic involvement in interpectoral (Rotter's) lymph nodes (RLN) in relation to tumor marker CA 15-3. METHODS The study included 177 female patients undergoing surgery for primary breast cancer at the University Hospital for Tumors, Zagreb, Croatia from November 2001 to March 2004. In addition to the standard surgical procedure, interpectoral RLNs were ...
متن کاملCombined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer
OBJECTIVE CA 15-3 is a traditional biomarker for advanced breast cancer with limited sensitivity for early stage patients. In order to increase the sensitivity for early detection, in this study, we introduced novel tumor-associated autoantibodies that were measured concurrently with serum CA 15-3 to evaluate their diagnostic advantage in breast cancer. METHODS We investigated a T7 breast can...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cancer Research and Clinical Oncology
سال: 1986
ISSN: 0171-5216,1432-1335
DOI: 10.1007/bf02580069